Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1675]

ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%

ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%

ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer

ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal...

New research platform assesses brain cancer mutations during surgery

New research platform assesses brain cancer mutations during surgery

New PET agent provides exceptional same-day imaging for clear cell renal cell carcinoma patients

New PET agent provides exceptional same-day imaging for clear cell renal cell carcinoma patients

Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery

Hospital first-in-paediatrics to use technology that lights up lung cancer during surgery

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after research shows improved outcomes for patients

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after research shows improved...

Genetically engineering a treatment for incurable brain tumours

Genetically engineering a treatment for incurable brain tumours

Tumour deposits in colorectal and gastric cancers

Tumour deposits in colorectal and gastric cancers

Immunotherapy post-surgery improves overall survival for kidney cancer

Immunotherapy post-surgery improves overall survival for kidney cancer

Lower relapse risk in triple-negative breast cancer with high immune cell levels

Lower relapse risk in triple-negative breast cancer with high immune cell levels

More from ecancer